首页> 外文期刊>Experimental Eye Research >Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy
【24h】

Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy

机译:来自糖尿病动物视网膜的转录组织分析揭示了与糖尿病视网膜病变的血管视网膜屏障改变相关的新型基因和分子途径

获取原文
获取原文并翻译 | 示例
           

摘要

Selective pericyte loss, the histological hallmark of early diabetic retinopathy (DR), enhances the breakdown of the blood-retinal barrier (BRB) in diabetes. However, the role of pericytes on BRB alteration in diabetes and the signaling pathways involved in their effects are currently unknown. To understand the role of diabetes-induced molecular alteration of pericytes, we performed transcriptomic analysis of sorted retinal pericytes from mice model of diabetes. Retinal tissue from non-diabetic and diabetic (duration 3 months) mouse eyes (n = 10 in each group) were used to isolate pericytes through fluorescent activated cell sorting (FAGS) using pericyte specific fluorescent antibodies, PDGFRb-APC. For RNA sequencing and qPCR analysis, a cDNA library was generated using template switching oligo and the resulting libraries were sequenced using paired-end Illumina sequencing. Molecular functional pathways were analyzed using differentially expressed genes (DEGs). Differential expression analysis revealed 217 genes significantly upregulated and 495 genes downregulated, in pericytes isolated from diabetic animals. These analyses revealed a core set of differentially expressed genes that could potentially contribute to the pericyte dysfunction in diabetes and highlighted the pattern of functional connectivity between key candidate genes and blood retinal barrier alteration mechanisms. The top up-regulated gene list included: Ext2, B3gat3, Gpc6, Pip5k1c and Pten and down-regulated genes included: Notch3, Xbp1, Gpc4, Atp1a2 and AKT3. Out of these genes, we further validated one of the down regulated genes, Notch 3 and its role in BRB alteration in diabetic retinopathy. We confirmed the downregulation of Notch3 expression in human retinal pericytes exposed to Advanced Glycation End-products (AGEs) treatment mimicking the chronic hyperglycemia effect. Exploration of pericyte-conditioned media demonstrated that loss of NOTCH3 in pericyte led to increased permeability of endothelial cell monolayers. Collectively, we identify a role for NOTCH3 in pericyte dysfunction in diabetes. Further validation of other DEGs to identify cell specific molecular change through whole transcriptomic approach in diabetic retina will provide novel insight into the pathogenesis of DR and novel therapeutic targets.
机译:选择性周刊丧失,早期糖尿病视网膜病变(DR)的组织学标志,增强了糖尿病患者血淋淋屏障(BRB)的分解。然而,周刊对糖尿病患者的BRB改变以及其效果中涉及的信号通路的作用目前未知。要了解糖尿病诱导的腹膜分子改变的作用,我们对糖尿病小鼠模型进行了转录的视网膜周细胞的转录组分析。来自非糖尿病和糖尿病(持续时间3个月)小鼠眼睛(每组N = 10)的视网膜组织用于通过使用本身特异性荧光抗体,PDGFRB-APC通过荧光活化的细胞分选(FAG)分离周细胞。对于RNA测序和QPCR分析,使用模板切换寡核苷酸产生cDNA文库,并使用配对端Illumina测序测序所得文库。使用差异表达基因(DEGS)分析分子官能途径。差异表达分析显示,从糖尿病动物分离的综合症中显着上调了217个基因,下调了495个基因。这些分析揭示了一种核心差异表达基因的核心组,其可能有助于糖尿病中的细胞功能障碍,并突出了关键候选基因和血管屏障改变机制之间的功能性连通性的模式。包括:EXT2,B3GAT3,GPC6,PIP5K1C和PTEN和下调基因包括:Notch3,XBP1,GPC4,ATP1A2和AKT3。在这些基因中,我们进一步验证了糖尿病视网膜病变的BRB改变中的下调基因,缺口3及其作用之一。我们证实了在暴露于慢性高血糖效应的晚期糖粉末期产物(年龄)治疗的人类视网膜膜中Notch3表达的下调。细胞条件介质的探索证明,周围的Notch3中的损失导致内皮细胞单层的渗透性增加。集体,我们鉴定了糖尿病患者的Pericyte功能障碍中Notch3的作用。通过糖尿病视网膜的整个转录组种方法进一步验证其他参数以鉴定细胞特异性分子变化将为博士和新型治疗靶标的发病机制提供新的洞察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号